Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00930_DB01357> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00930_DB01357 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00930_DB01357 label "DDI between Colesevelam and Mestranol - Bile Acid Sequestrants may decrease the serum concentration of Contraceptives (Estrogens). Administer estrogen-based oral contraceptives at least 1-4 hours prior to or 4-6 hours after administration of a bile acid sequestrant. Consider alternatives in order to avoid this combination when possible, due to the risk for impaired contraceptive effectiveness. Ethinyl estradiol patches and vaginal rings may also be somewhat impacted by this interaction, though the extent and significance of such an interaction is uncertain. [drugbank_resource:DB00930_DB01357]" assertion.
- drugbank_resource:DB00930_DB01357 identifier "drugbank_resource:DB00930_DB01357" assertion.
- drugbank_resource:DB00930_DB01357 title "DDI between Colesevelam and Mestranol - Bile Acid Sequestrants may decrease the serum concentration of Contraceptives (Estrogens). Administer estrogen-based oral contraceptives at least 1-4 hours prior to or 4-6 hours after administration of a bile acid sequestrant. Consider alternatives in order to avoid this combination when possible, due to the risk for impaired contraceptive effectiveness. Ethinyl estradiol patches and vaginal rings may also be somewhat impacted by this interaction, though the extent and significance of such an interaction is uncertain." assertion.